The clinical analysis of borderline epithelial ovarian tumors

Xudong LIANG,Haoxia ZENG,Yi LI,Honglan ZHU,Danhua SEN,Xiaoyun LIAO,Heng CUI,Lihui WEI

DOI: https://doi.org/10.3969/j.issn.1672-1861.2010.06.003

2010-01-01

Abstract:Objective To investigate the clinical features,management and prognosis of borderline epithelial ovarian tumors(BOT).To study the factors influencing the recurrence and prognosis of BOT.Methods The data of 130 BOT patients diagnosed by surgery and pathology(Peking University People's Hospital,January 1980 to August 2009)were analyzed retrospectively.The postoperative follow-up period ranged from 12 to 240 months.Results The average onset age was 42.3 years old.There were 106 cases of stage Ⅰ,6 cases of stage Ⅱ,18 cases of stage Ⅲ.48 cases were serous,63 cases were mucinous.49.0% patients were with elevated CA125.1% with micropapillary and 0.05% with infiltrative implantation.All patients received operation and 42.3% underwent fertility-sparing procedures.8 cases(6%)relapsed,2 of 18 cases who underwent ovarian cystectomy relapsed.None of the 34 cases who underwent unilateral or bilateral salpingo-oophorectomy relapsed.Five or ten-years survival rate of patients who underwent staging operation,unilateral salpingo-oophorectomy or ovarian cystectomy were 100%,100% and 95%,respectively.Conclusions Onset age of borderline epithelial ovarian tumors was younger,more common in mucinous pathologic type,the majority of patients were stage Ⅰ and the prognosis was good.Surgery is the main effective approach for BOT patients.For those with early stage,fertility-sparing surgery is indicated.Micropapillary,infiltrative implantation,residual disease of primary surgery and FIGO tumor stage are factors influencing the recurrence and prognosis.